InMode to Present at Upcoming Investor Conferences
Rhea-AI Summary
InMode (Nasdaq: INMD) will present at two investor conferences in March 2026: Barclays 28th Annual Global Healthcare Conference and Oppenheimer 36th Annual Healthcare MedTech & Services Conference.
Presenters: Yair Malca, CFO (Barclays); Moshe Mizrahy, CEO, and Yair Malca, CFO (Oppenheimer). Webcasts are scheduled for March 11 and March 16.
Positive
- None.
Negative
- None.
YOKNEAM,

Barclays 28th Annual Global Healthcare Conference
Presenters: Yair Malca, Chief Financial Officer
Format: In-person fireside chat moderated by Matt Miksic, Senior Equity Analyst, and one-on-one meetings
Location:
When: Wednesday, March 11 at 12:30 pm ET
A live webcast of the presentation can be accessed here.
Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Presenters: Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer
Format: Virtual fireside chat moderated by Suraj Kalia, Senior Equity Analyst, and one-on-one meetings
When: Monday, March 16 at 1:20 pm ET
A live webcast of the presentation can be accessed here.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Forward-Looking Statements
The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the 2026 revenue projection described above. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 4, 2025, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/inmode-to-present-at-upcoming-investor-conferences-302697407.html
SOURCE InMode LTD